XML 36 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
STOCKHOLDERS' DEFICIT (Tables)
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of Share-Based Payment Arrangement, Cost by Plan
The following table presents the Company's total share based compensation expense by award type for the three months ended March 31, 2024 and 2023:

(In thousands)Three Months Ended
March 31,
20242023
RSUs$4,926 $6,102 
Performance RSUs2,789 1,931 
Options765 2,119 
Total Share Based Compensation Expense(1)
$8,480 $10,152 
(1) Total share based compensation expense includes $0.5 million of expense from cash settled awards for the three months ended March 31, 2024
Schedule of Computation of Income (Loss) per Share
(In thousands, except per share data)Three Months Ended
March 31,
 20242023
NUMERATOR:  
Net loss attributable to the Company – common shares$(18,508)$(222,260)
DENOMINATOR(1):
 
Weighted average common shares outstanding - basic149,795 148,365 
  Stock options and restricted stock(2):
— — 
Weighted average common shares outstanding - diluted149,795 148,365 
Net loss attributable to the Company per common share: 
Basic$(0.12)$(1.50)
Diluted(0.12)(1.50)
(1) All of the outstanding Special Warrants are included in both the basic and diluted weighted average common shares outstanding of the Company for the three months ended March 31, 2024 and 2023.
(2) Outstanding equity service awards representing 15.8 million and 11.7 million shares of Class A common stock of the Company for the three months ended March 31, 2024 and 2023, respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive.